miscsubjectsautonomous operating environment
Evidence review

SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-cognition`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-cognition

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-cognition/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-cognition/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-cognition/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-cognition/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

Cognition depends on neurons having steady energy from mitochondria. When those organelles lose cardiolipin stability, electron transport leaks, reactive oxygen species rise, and ATP drops. Synapses weaken. Inflammation can follow. Over time the repair side falls behind the daily wear, and memory, focus, or processing speed show it. No single drug masks that; repair at the mitochondrial membrane is what gets discussed for this layer.

Why SS-31 (Elamipretide) might help you

SS-31 binds cardiolipin in the inner mitochondrial membrane.

  1. If your neurons have excess ROS from leaky mitochondria, the peptide is studied because it stabilizes cardiolipin and lowers electron leak.
  2. If ATP production is down, the same stabilization supports complex activity and ATP output in preclinical models.
  3. If synaptic proteins are declining, reduced oxidative damage and better energy are the pathways linked to preserved dendritic spines and memory performance in animal work.
  4. Therefore for you: If mitochondrial dysfunction sits at the root of your cognitive layer, SS-31 is discussed because it targets repair at the membrane — not because it suppresses symptoms.

How these fit together

Single-compound focus. SS-31 maps to the mitochondrial layer. If your profile includes other degeneration layers, separate compounds would address those; this one stays on cardiolipin stabilization and downstream energy/ROS effects.

What the evidence actually shows

Preclinical only for cognition. No human trials test SS-31 on memory, executive function, or dementia endpoints. All listed studies used rodents.

  • In one mouse study, lipopolysaccharide triggered hippocampal mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired Morris water maze and fear conditioning performance. SS-31 treatment reduced those deficits and improved behavioral scores (preclinical tier, source s1).
  • In developing rats exposed to isoflurane, SS-31 pretreatment limited mitochondrial deformation, neuronal apoptosis, and later cognitive deficits measured at postnatal day 40–60 (preclinical tier, source s2).
  • Aged mice treated with SS-31 showed improved neurovascular coupling and spatial working memory versus vehicle (preclinical tier, source s3).
  • Sleep-deprived mice models showed SS-31 restored SIRT1/PGC-1α signaling and reduced inflammatory cytokines alongside better cognitive scores (preclinical tier, source s4).

Human data: Eighteen clinical trials exist for other indications (Barth syndrome, heart failure, mitochondrial myopathy). None measured cognition as primary or secondary outcome. A 2025 review states zero clinical trials for dementia prevention or treatment and notes effects “have not been confirmed in humans” (human tier: absent, source s5).

What scientists say

Researchers describe SS-31 as a cardiolipin-targeting antioxidant that improves mitochondrial bioenergetics and reduces ROS in cell and rodent models of neuroinflammation, ischemia, and aging. They emphasize the gap: promising mechanistic and animal data, yet no controlled human cognition studies. Visual-function recovery in aged mice after SS-31 is cited as supporting mitochondrial involvement in age-related decline, but translation to cognition remains untested (mechanistic/preclinical tier).

What people say on Reddit

Anecdotal reports appear mainly in chronic fatigue and long-COVID communities. Users describe subjective lifts in brain fog, sustained mental energy, or clearer thinking after courses of SS-31; others report no noticeable change or transient fatigue. Doses and durations vary widely; self-experimentation is common. These remain individual experiences without controls or objective testing (anecdotal tier).

What people say on X

Public posts on X are sparse and largely echo general mitochondrial-peptide interest rather than specific cognition outcomes. No consistent pattern of reported cognitive changes appears in searchable recent discussion.

What we do not know

  • Whether any cognitive benefit occurs in humans.
  • Optimal timing, duration, or patient subgroup for mitochondrial support in the brain.
  • Long-term effects on healthy cognition or interaction with common medications.
  • How results from induced-injury rodent models translate to gradual age-related or idiopathic decline.

Safety and limits

SS-31 has completed multiple human trials for non-cognitive indications with generally acceptable tolerability in those populations. It received FDA approval in 2025 for Barth syndrome. No cognition-specific safety dataset exists. All cognitive claims rest on preclinical work; human extrapolation is speculative at present.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 5 claims are extracted and stored on the object.
  • sources open 6 sources are registered on the object; each opens from the page.
  • claims bound 5 of 5 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/ss-31-cognition/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/ss-31-cognition/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/ss-31-cognition?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/ss-31-cognition/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Cognition / focus · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSS-31 (Elamipretide) Mitochondrial Targeting with GLP-1 Agonists: Evid… · 3 humanSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence… · 2 humanSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc… · 2 humanSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid… · 2 human
Evidence · 6 sources · swipe →chain 5b07ccad97e9 · verify chain · provenance
1 / 6
Study
Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
pretreatment with elamipretide not only provided protective effect against oxidative stress and mitochondrial damages, but also attenuated isoflurane-induced cognitive deficits.
Identifier corrected 2026-08-05: it read PMID 28421000, which is "Photodynamic Physiology-Photonanomanipulations in Cellular Physiology with Protein Photosensitizers". Verified against PubMed that 28487636 is the paper this citation names. Rat developmental anesthesia model with cognitive protection.
· PMID: 28487636
2026-06-29 23:56s2 · #a132ed6088fe

Key evidence

5 claims · tier-ranked · API
humanlow confidence
No human clinical trials have tested SS-31 on cognition or dementia endpoints.
sources: s5
preclinicallow confidence
In LPS-treated mice, SS-31 reduced hippocampal mitochondrial dysfunction and improved Morris water maze performance.
sources: s1
preclinicallow confidence
SS-31 pretreatment in isoflurane-exposed rat pups limited later cognitive deficits measured at PND 40–60.
sources: s2
preclinicallow confidence
Aged mice receiving SS-31 showed improved spatial working memory versus vehicle controls.
sources: s3
anecdotallow confidence
Reddit users with CFS or long COVID report subjective improvements in brain fog or mental energy after SS-31; others report none.
sources: s6
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:57
SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded · 5 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Cognition
Slug: ss-31-cognition
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"deg
it output
{
  "slug": "ss-31-cognition",
  "title": "SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded",
  "body": "## What's breaking down\n\nCognition depends on neurons having steady energy from mitochondria. When those organelles lose cardiolipin stability, electron transport leaks, reactive oxygen species rise, and ATP drops. Synapses weaken. Inflammation can follow. Over time the repair side falls behind the daily wear, and memory, focus, or processing speed show it. No single drug masks that; repair at the mitochondrial membrane is what gets discussed for this layer.\n\n## Why SS-31 (Elamipretide) might help you\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane.\n\n1. If your neurons have excess ROS from leaky mitochondria, the peptide is studied because it stabilizes cardiolipin and lowers electron leak.\n2. If ATP production is down, the same stabilization supports complex activity and ATP output in preclinical models.\n3. If synaptic proteins are declining, reduced oxidative damage and better energy are the pathways linked to preserved dendritic spines and memory performance in animal work.\n4. Therefore for you: If mitochondrial dysfunction sits at the root of your cognitive layer, SS-31 is discussed because it targets repair at the membrane — not because it suppresses symptoms.\n\n## How these fit together\n\nSingle-compound focus. SS-31 maps to t
8d0f5fb38c80593a
Machine verification: /api/articles/ss-31-cognition/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

Cognition / focus · condition map

Open evidence map →
Ss 31ss-31SS-31 (Elamipretide) for Benzodiazepine Withdrawal: Mitochondrial Repa…ss-31-benzo-withdrawalSS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a…ss-31-benzodiazepinesSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence…ss-31-brain-fogSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc…ss-31-carpal-tunnelSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid…ss-31-chemo
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human clinical trials have tested SS-31 on cognition or dementia endpoints."?
ask ss-31-cognition claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In LPS-treated mice, SS-31 reduced hippocampal mitochondrial dysfunction and improved Morris water maze performance."?
ask ss-31-cognition claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "SS-31 pretreatment in isoflurane-exposed rat pups limited later cognitive deficits measured at PND 40–60."?
ask ss-31-cognition claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Aged mice receiving SS-31 showed improved spatial working memory versus vehicle controls."?
ask ss-31-cognition claim c4 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users with CFS or long COVID report subjective improvements in brain fog or mental energy after SS-31; others report none."?
ask ss-31-cognition claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports on cognitive effects in CFS context."
ask ss-31-cognition source s6 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded — and what would you need me to tell you first?
ask ss-31-cognition condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded (studies vs anecdotes)?
ask ss-31-cognition good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fss-31-cognition%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/ss-31-cognition/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/ss-31-cognition/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3